Sequencing Strategies After Progression to mCRPC | Urology Times
Sequencing Strategies After Progression to mCRPC | Urology …
1 month ago
urologytimes.com
Administering Radium-223 for mCRPC | OncLive
Administering Radium-223 for mCRPC | OncLive
May 17, 2015
onclive.com
Maximizing survival in metastatic castration-resistant prostate cancer (mCRPC) - ecancer
Maximizing survival in metastatic castration-resistant prostate canc…
3.5K viewsJan 10, 2014
ecancer.org
Defining Unmet Needs in the Management of mCRPC | OncLive
Defining Unmet Needs in the Management of mCRPC | OncLive
May 12, 2022
onclive.com
3.5K views · 21 reactions |  What is metastatic castration-resistant prostate cancer (mCRPC)? It's a stage of prostate cancer where the disease continues to progress despite low testosterone levels. Dr. Alicia Morgans delivers an important message for patients diagnosed with small cell or high-grade neuroendocrine tumors. | Prostate Cancer Foundation | Facebook
0:39
3.5K views · 21 reactions |  What is metastatic castration-resistant pro…
1.3K views1 week ago
FacebookProstate Cancer Foundation
In 2018, Bob received the news he has metastatic castration-resistant...
0:35
In 2018, Bob received the news he has metastatic castration-resistant...
11.9K views1 week ago
FacebookBayer U.S.
Evolving Treatment Landscape in Metastatic Castration-Resistant Prostate Cancer (mCRPC) | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
Evolving Treatment Landscape in Metastatic Castration-Resistant Pr…
9 months ago
targetedonc.com
Counseling Patients With mCRPC | OncLive
4 weeks ago
onclive.com
Case Study: Minimally Symptomatic mCRPC | OncLive
Jul 10, 2013
onclive.com
Case Study: Symptomatic, Progressing mCRPC | OncLive
Jun 11, 2015
onclive.com
Evolution of Treatment for mCRPC | OncLive
May 28, 2014
onclive.com
Performance Status in Progressive mCRPC | OncLive
Jun 11, 2015
onclive.com
The Differences Between mCRPC and nmCRPC | Targeted Oncolog…
Jul 17, 2019
targetedonc.com
The Evolution of Treatment Paradigms in Metastatic Castratio…
Apr 17, 2023
onclive.com
2L Treatment Options and Decision-Making Considerations in mCRPC …
246 views10 months ago
vumedi.com
Dr. Agarwal on the Safety Profile of Olaparib in HRR Gene-Mutant mC…
Aug 4, 2020
onclive.com
Bone Versus Visceral Metastases in mCRPC | Targeted Oncology - Im…
Oct 29, 2018
targetedonc.com
The Value of Therapeutic Layering in mCRPC | OncLive
Oct 12, 2017
onclive.com
Dr Garje on Emerging Biomarkers in mCRPC | OncLive
May 15, 2024
onclive.com
Dr. Scholz on Using Abiraterone in mCRPC | OncLive
Mar 4, 2015
onclive.com
Dr. Charles Ryan on Abiraterone in mCRPC
Mar 9, 2015
onclive.com
Dr. Tagawa on the Evolution of ADCs in mCRPC | OncLive
1 week ago
onclive.com
Dr. Dorff on Current Agents for Patients With mCRPC | OncLive
Nov 16, 2017
onclive.com
Dr. Antonarakis Describes the TAXYNERGY Trial in mCRPC | On…
Feb 25, 2013
onclive.com
Dr. Crawford on Ongoing Research With Radium-223 in mCRPC | Onc…
Jul 15, 2016
onclive.com
Dr. Stock on the Optimal Use of Radium-223 in mCRPC
Apr 25, 2016
onclive.com
Dr. Oh on Validating Gene Signatures in mCRPC | OncLive
2 weeks ago
onclive.com
Clinical Considerations Related to Lutetium 177– PSMA-617 Treatme…
Aug 2, 2022
curetoday.com
FDA Approval in Sarcoma, Priority Reviews in mCRPC and Myeloma, …
Jan 29, 2020
onclive.com
2:09
Phase III #PSMAfore trial: Final survival and safety data in #mCRP…
8 views2 weeks ago
FacebookUroToday
See more videos
Static thumbnail place holder